# NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression

> **NCT04364828** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 1000 (actual)

## Conditions studied

- COVID-19

## Interventions

- **GENETIC:** Whole Genome Analysis
- **GENETIC:** T-cell receptor (TCR) repertoire
- **GENETIC:** SARS-CoV-2 viral composition

## Key facts

- **NCT ID:** NCT04364828
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-21
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-08-31
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04364828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04364828, "NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04364828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*